Search Results - Dan Douer

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Recognition, prevention, and management of adverse events associated with asparaginase / pegaspargase treatment of acute lymphoblastic leukemia in adults: consensus of an expert pa... by Emily Curran, Marlise R. Luskin, Houda Alachkar, Ibrahim Aldoss, Patrick W. Burke, Ryan D. Cassaday, Seth E. Karol, Anthony J. Perissinotti, Cecilie Utke Rank, Kjeld Schmiegelow, Jonathan Webster, Dan Douer

    Published in Haematologica (2025-03-01)
    Get full text
    Article


  2. 2

    Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to age 60 with Philadelphia chromos... by Mark B. Geyer, Ellen K. Ritchie, Arati V. Rao, Shreya Vemuri, Jessica Flynn, Meier Hsu, Sean M. Devlin, Mikhail Roshal, Qi Gao, Madhulika Shukla, Jose M. Salcedo, Peter Maslak, Martin S. Tallman, Dan Douer, Jae H. Park

    Published in Haematologica (2020-10-01)
    Get full text
    Article


  3. 3

    Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia by Peter G. Maslak, Tao Dao, Yvette Bernal, Suzanne M. Chanel, Rong Zhang, Mark Frattini, Todd Rosenblat, Joseph G. Jurcic, Renier J. Brentjens, Maria E. Arcila, Raajit Rampal, Jae H. Park, Dan Douer, Laura Katz, Nicholas Sarlis, Martin S. Tallman, David A. Scheinberg

    Published in Blood Advances (2018-02-01)
    Get full text
    Article


Search Tools: